The expression of Ki-67 marker in the hydatidiform mole

Background: The hydatiform mole is charcaterized by a pathological proliferation of the trophoblast. Its evaluation could predict the progression to gestational trophoblastic neoplasia. The aim of the study was the analysis of the proliferative activity of the villous trophoblast in the molar vs non...

Full description

Bibliographic Details
Main Authors: Ecaterina Carpenco, Vergil Petrovici, Lilia Sinitina, Veaceslav Fulga, Valeriu David
Format: Article
Language:English
Published: Scientific Medical Association of Moldova 2022-12-01
Series:The Moldovan Medical Journal
Subjects:
Online Access:https://moldmedjournal.md/wp-content/uploads/2022/12/moldovan-med-j-2022-65-2-carpenco-et-al-full-text.pdf
_version_ 1828085687601070080
author Ecaterina Carpenco
Vergil Petrovici
Lilia Sinitina
Veaceslav Fulga
Valeriu David
author_facet Ecaterina Carpenco
Vergil Petrovici
Lilia Sinitina
Veaceslav Fulga
Valeriu David
author_sort Ecaterina Carpenco
collection DOAJ
description Background: The hydatiform mole is charcaterized by a pathological proliferation of the trophoblast. Its evaluation could predict the progression to gestational trophoblastic neoplasia. The aim of the study was the analysis of the proliferative activity of the villous trophoblast in the molar vs non-molar lesions. Material and methods: p-57 and Ki-67 were evaluated by immunohistochemistry in 15 cases of hydatidiform mole and 18 cases of abortions. Results: The hydatidiform mole was divided based on the immunoexpression of anti-p57 into: complete (8 cases) and partial type (7 cases). The distribution score of Ki67 immunoreactivity in the villous cytotrophoblast was: complete mole: +3 – 8 cases; partial mole: +1 – 1 case, +2 – 3 cases, +3 – 3 cases; abortions on social indications: +1 – 6 cases, +2 – 9 cases; +3 – 2 cases. The mean and standard deviations were: 2.88±0.354; 2.29±0.756 and 1.82±0.728, respectively. The following statistical correlations were determined: complete vs partial mole (p=0.014), complete mole vs abortion (p<0.01) and overall cases of mole vs abortion (p=0.000034). Conclusions: Villous cytotrophoblast proliferative activity is high in the complete hydatidiform mole, and the immunoreactivity distribution index is highly positive and statistically true in the molar versus non-molar group. Immunohistochemical evaluation of Ki-67 in molar pathology is useful in differential diagnosis as a complementary method.
first_indexed 2024-04-11T04:43:25Z
format Article
id doaj.art-6d77de6090034aa2922f6c7a81e88be5
institution Directory Open Access Journal
issn 2537-6373
2537-6381
language English
last_indexed 2024-04-11T04:43:25Z
publishDate 2022-12-01
publisher Scientific Medical Association of Moldova
record_format Article
series The Moldovan Medical Journal
spelling doaj.art-6d77de6090034aa2922f6c7a81e88be52022-12-27T18:55:40ZengScientific Medical Association of MoldovaThe Moldovan Medical Journal2537-63732537-63812022-12-016521319https://doi.org/10.52418/moldovan-med-j.65-2.22.02The expression of Ki-67 marker in the hydatidiform moleEcaterina Carpenco0https://orcid.org/0000-0003-1464-3149Vergil Petrovici1https://orcid.org/0000-0001-8352-4202Lilia Sinitina2https://orcid.org/0000-0001-9646-8860Veaceslav Fulga3https://orcid.org/0000-0002-7589-7188Valeriu David4https://orcid.org/0000-0001-9799-7369Nicolae Testemitanu State University of Medicine and Pharmacy, Chisinau, the Republic of MoldovaNicolae Testemitanu State University of Medicine and Pharmacy, Chisinau, the Republic of MoldovaNicolae Testemitanu State University of Medicine and Pharmacy, Chisinau, the Republic of MoldovaNicolae Testemitanu State University of Medicine and Pharmacy, Chisinau, the Republic of MoldovaNicolae Testemitanu State University of Medicine and Pharmacy, Chisinau, the Republic of MoldovaBackground: The hydatiform mole is charcaterized by a pathological proliferation of the trophoblast. Its evaluation could predict the progression to gestational trophoblastic neoplasia. The aim of the study was the analysis of the proliferative activity of the villous trophoblast in the molar vs non-molar lesions. Material and methods: p-57 and Ki-67 were evaluated by immunohistochemistry in 15 cases of hydatidiform mole and 18 cases of abortions. Results: The hydatidiform mole was divided based on the immunoexpression of anti-p57 into: complete (8 cases) and partial type (7 cases). The distribution score of Ki67 immunoreactivity in the villous cytotrophoblast was: complete mole: +3 – 8 cases; partial mole: +1 – 1 case, +2 – 3 cases, +3 – 3 cases; abortions on social indications: +1 – 6 cases, +2 – 9 cases; +3 – 2 cases. The mean and standard deviations were: 2.88±0.354; 2.29±0.756 and 1.82±0.728, respectively. The following statistical correlations were determined: complete vs partial mole (p=0.014), complete mole vs abortion (p<0.01) and overall cases of mole vs abortion (p=0.000034). Conclusions: Villous cytotrophoblast proliferative activity is high in the complete hydatidiform mole, and the immunoreactivity distribution index is highly positive and statistically true in the molar versus non-molar group. Immunohistochemical evaluation of Ki-67 in molar pathology is useful in differential diagnosis as a complementary method.https://moldmedjournal.md/wp-content/uploads/2022/12/moldovan-med-j-2022-65-2-carpenco-et-al-full-text.pdfhydatidiform moleki-67trophoblastic proliferation
spellingShingle Ecaterina Carpenco
Vergil Petrovici
Lilia Sinitina
Veaceslav Fulga
Valeriu David
The expression of Ki-67 marker in the hydatidiform mole
The Moldovan Medical Journal
hydatidiform mole
ki-67
trophoblastic proliferation
title The expression of Ki-67 marker in the hydatidiform mole
title_full The expression of Ki-67 marker in the hydatidiform mole
title_fullStr The expression of Ki-67 marker in the hydatidiform mole
title_full_unstemmed The expression of Ki-67 marker in the hydatidiform mole
title_short The expression of Ki-67 marker in the hydatidiform mole
title_sort expression of ki 67 marker in the hydatidiform mole
topic hydatidiform mole
ki-67
trophoblastic proliferation
url https://moldmedjournal.md/wp-content/uploads/2022/12/moldovan-med-j-2022-65-2-carpenco-et-al-full-text.pdf
work_keys_str_mv AT ecaterinacarpenco theexpressionofki67markerinthehydatidiformmole
AT vergilpetrovici theexpressionofki67markerinthehydatidiformmole
AT liliasinitina theexpressionofki67markerinthehydatidiformmole
AT veaceslavfulga theexpressionofki67markerinthehydatidiformmole
AT valeriudavid theexpressionofki67markerinthehydatidiformmole
AT ecaterinacarpenco expressionofki67markerinthehydatidiformmole
AT vergilpetrovici expressionofki67markerinthehydatidiformmole
AT liliasinitina expressionofki67markerinthehydatidiformmole
AT veaceslavfulga expressionofki67markerinthehydatidiformmole
AT valeriudavid expressionofki67markerinthehydatidiformmole